Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy

European Heart Journal

Volumn 20, Issue 18, 1999, Pages 1342-1354

  Gietzen, F H ^a,b   Leuner, Ch J ^a   Raute Kreinsen, U ^a   Dellmann, A ^a   Hegselmann, J ^a   Strunk Mueller, C ^a   Kuhn, H J ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b OWL University   (Germany)

Author keywords

Cardiac hypertrophy; Catheter interventional therapy; Effect of ethanol; Therapy of hypertrophic obstructive cardiomyopathy

Indexed keywords

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; CATHETER ABLATION; CLINICAL ARTICLE; CORONARY ARTERY; EXERCISE; FEMALE; HEART CATHETERIZATION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE FILLING PRESSURE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HEMODYNAMICS; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; SYMPTOM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; ETHANOL; EXERCISE; FEMALE; HEART CATHETERIZATION; HEART SEPTUM; HEMODYNAMIC PROCESSES; HUMANS; HYPERTROPHY; MALE; MIDDLE AGED; SCLEROSING SOLUTIONS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0032823413     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1520     Document Type: Article

References (40)

1. Loogen F, Kühn H, Gietzen F, Lösse B, Schulte D, Birks W. Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic nonobstructive cardiomyopathy. Eur Heart J 1983; 4 (Suppl F): 145-53.
2. Kuhn H, Gietzen F, Mercier J, et al. Studies of the clinical picture, course, and prognosis of different forms of hypertrophic cardiomyopathy. Z Kardiol 1983; 72: 83-98.
3. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987; 316: 780-9 844-52.
4. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 1995; 92: 1680-92.
5. Spirito P, Seidman CE, McKenna WJ, Maron BJ. Medical progress: The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336: 775-85.
6. Haberer T, Hess OM, Jenni R, Krayenbuhl HP. Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propanolol and verapamil. Z Kardiol 1983; 72: 487-93.
7. Rosing DR, Condit JR, Maron BJ, et al. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. Am J Cardiol 1981; 48: 545-53.
8. Maron BJ, Epstein SE, Morrow AG. Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy. Eur Heart J 1983; 4 (Suppl F): 175-85.
9. Schulte HD, Gramsch-Zabel H, Schwartzkopff R. Hypertrophic obstructive cardiomyopathy (HOCM): surgical management. Schweiz Med Wochenschr 1995; 125: 1940-9.
10. Schoendube FA, Klues HG, Reith S, Flachskampf FA, Hanrath P, Messmer BJ. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation 1995; 92 (Suppl II): II-122-31.
11. McIntosh CL, Maron BJ, Cannon III RO, Klues HG. Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. Circulation 1992; 86 (Suppl II): II-60-7.
12. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber pacing in obstructive hypertrophic cardiomyopathy. Circulation 1994; 90: 2731-42.
13. Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992; 339: 1318-23.
14. Kappenberger L, Linde C, Daubert C, et al and the PIC Study Group. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. Eur Heart J 1997; 18: 1249-56.
15. Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial. J Am Coll Cardiol 1997; 29: 435-41.
16. Strunk-Mueller C, Gietzen F, Kuhn H. Unchanged hemodynamics in DDD pacemaker stimulation because of hypertrophic cardiomyopathy in subjective clinical improvement (Abstr). Eur Heart J 1996; 17 (Abstr Suppl): 170.
17. Gietzen F, Leuner Ch, Gerenkamp Th, Kuhn H. Relief of obstruction in hypertrophic cardiomyopathy by transient occlusion of the first septal branch of the left coronary artery (Abstr). Eur Heart J 1994; 15 (Abstr Suppl): 125.
18. Kuhn H, Gietzen F, Leuner Ch, Gerenkamp Th. Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy: studies to develop a new catheter-based concept of treatment. Eur Heart J 1997; 18: 846-51.
19. Inoue H, Waller BF, Zipes DP. Intracoronary ethylalcohol or phenol injection ablates aconitine-induced ventricular tachycardia in dogs. J Am Coll Cardiol 1987; 10: 1342-9.
20. Haines DE, Whayne JG, Di Marco JP. Intracoronary ethanol ablation in Swine: Effects of ethanol concentration on lesion formation and response to programmed ventricular stimulation. J Cardiovasc Electrophysiol 1994; 5: 422-31.
21. Brugada P, de Swart HB, Bär FWHM, Smeets JLRM, van Ommen V, Wellens HJJ. Transcoronary termination and chemical ablation of arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology - From Cell to Bedside. Philadelphia: Saunders, 1990; 1005-14.
22. Kay GN, Epstein AE, Bubien RS, Anderson PG, Daily SM, Plumb VJ. Intracoronary ethanol ablation for the treatment of recurrent sustained ventricular tachycardia. J Am Coll Cardiol 1992; 19: 159-68.
23. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995; 346: 211-4.
24. Gietzen F, Leuner Ch, Gerenkamp Th, Kuhn H. Katheterinterventionelle Therapie der hypertrophisch obstruktiven Kardiomyopathie durch Alkoholablation des ersten Septalastes der linken Koronararterie (Abstr). Z. Kardiol 1996; 85 (Suppl 2): 3.
25. Gleichmann U, Seggewiß H, Faber L, Faßbender D, Schmidt HK, Strick S. Kathetertherapie der hypertrophen obstruktiven Kardiomyopathie. Dtsch med Wschr 1996; 121: 679-85.
26. Knight Ch, Kurbaan AS, Seggewiss H, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy. Outcome in the first series of patients. Circulation 1997; 95: 2075-81.
27. Lakkis N, Kleiman N, Killip D, Spencer WH III. Hypertrophic obstructive cardiomyopathy: alternative therapeutic options. Clin Cardiol 1997; 20: 417-8.
28. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998; 31: 252-8.
29. Faber L, Seggewiß H, Strick S, Bogunovic N, Gleichmann U. Intra-procedural myocardial contrast echocardiography: a routine procedure in percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy (Abstr). Eur Heart J 1998; 19 (Abstr Suppl): 12.
30. Sahn DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
31. Gilbert BW, Pollick C, Adelman AG, Wigle ED. Hypertrophic cardiomyopathy: subclassification by M-mode echocardiography. Am J Cardiol 1980; 45: 861-72.
32. Sellers RD, Levy MJ, Amplatz K, Lillehei CW. Left retrograde cardioangiography in acquired cardiac disease. Technic, indications and interpretations in 700 cases. Am J Cardiol 1964; 14: 437-47.
33. Lösse B, Loogen F, Schulte HD. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies. Z Kardiol 1987; 76 (Suppl 3): 119-30.
34. Denniss AR, Richards DA, Cody DV et al. Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction. Circulation 1986; 74: 731-45.
35. Maron BJ, Merrill WH, Freier PA Kent KM, Epstein SE, Morrow AG. Long term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation 1978; 57: 1205-13.
36. Borggrefe M. Ergebnisse zur Hochfrequenzstromablation der atrioventriculären Überleitung. In: Borggrefe M, ed. Katheterablation tackykarder Herzrhythmus-störungen mittels Hochfrequenzstrom. Steinkopff Darmstadt 1994; 58-61.
37. McAreavey D, Fananapazir L. Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy. Am J Cardiol 1992; 70: 651-6.
38. Gietzen FH, Kuhn H, Leuner ChJ, Hegselmann J, Strunk-Mueller C. Acute and long-term results after transcoronary ablation of septum hypertrophy by selective septal branch injection of ethanol. A catheter interventional treatment for hypertrophic obstructive cardiomyopathy (Abstr). Circulation 1998; 98 (Suppl I): I-86.
39. Braunwald E. A new treatment for hypertrophic cardiomyopathy? Eur Heart J 1997; 18: 709-10.
40. Braunwald E. Induced septal infarction. A new therapeutic strategy for hypertrophic obstructive cardiomyopathy Circulation 1997; 95:1981-2.